China Health : RESIGNATION OF NON-EXECUTIVE DIRECTOR AND CHANGE OF AUTHORISED REPRESENTATIVE

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

China Health Group Limited ʕ਷ሊ͛ණྠϞࠢʮ̡

(Carrying on business in Hong Kong as CHG HS Limited)

(Incorporated in Bermuda with limited liability)

(Stock Code: 673)

RESIGNATION OF NON-EXECUTIVE DIRECTOR AND

CHANGE OF AUTHORISED REPRESENTATIVE

The board of directors (the "Board") of China Health Group Limited (the "Company") announces that with effect from 8 March 2021, Mr. Weng Yu ("Mr. Weng") has resigned as the non-executive Director of the Company due to his other personal pursuits and business commitments and ceased to act as the authorised representative of the Company under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules").

The Board further announces that Mr. Chung Ho, the executive Director of the Company, has been appointed as the authorized representative of the Company under Rule 3.05 of the Listing Rules in replacement of Mr. Weng with effect from 8 March 2021.

Mr. Weng has confirmed that he has no disagreement with the Board and there are no matters in relation to his resignation which should be brought to the attention of the shareholders of the Company and The Stock Exchange of Hong Kong Limited.

The Board would like to take this opportunity to express its sincere gratitude to Mr. Weng for his valuable contribution to the Company during his tenure of office.

By Order of the Board

China Health Group Limited

Zhang Fan

Chairman of the Board and Executive Director

Hong Kong, 8 March 2021

As at the date of this announcement, the Board comprises three executive Directors, namely, Mr.

Zhang Fan (chairman), Mr. Chung Ho and Mr. Wang Jingming; two non-executive Directors, namely, Mr. Xing Yong and Mr. Huang Lianhai; and four independent non-executive Directors, namely, Mr. Jiang Xuejun, Mr. Du Yanhua, Mr. Lai Liangquan and Ms. Meng Junfeng.